MENU
+Compare
NEPH
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$3.57
Change
+$0.13 (+3.78%)
Capitalization
23.09M

NEPH Nephros Forecast, Technical & Fundamental Analysis

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets... Show more

NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NEPH with price predictions
Jul 25, 2025

Momentum Indicator for NEPH turns negative, indicating new downward trend

NEPH saw its Momentum Indicator move below the 0 level on July 07, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned negative. In of the 89 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for NEPH turned negative on June 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NEPH advanced for three days, in of 203 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 127 cases where NEPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NEPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.775) is normal, around the industry mean (24.533). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.605) is also within normal values, averaging (43.112).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NEPH is expected to report earnings to fall 120.00% to 0 cents per share on August 06

Nephros NEPH Stock Earnings Reports
Q2'25
Est.
$-0.01
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.01
The last earnings report on May 08 showed earnings per share of 5 cents, beating the estimate of 0 cents. With 22.95K shares outstanding, the current market capitalization sits at 23.09M.
A.I. Advisor
published General Information

General Information

a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
380 Lackawanna Place
Phone
+1 201 343-5202
Employees
31
Web
https://www.nephros.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CING5.500.13
+2.42%
Cingulate Inc
CMI369.524.25
+1.16%
Cummins
AVNS12.010.13
+1.09%
Avanos Medical
KVAC11.490.12
+1.06%
Keen Vision Acquisition Corp
RELY16.98-0.18
-1.05%
Remitly Global

NEPH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with SGHT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then SGHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
+3.78%
SGHT - NEPH
34%
Loosely correlated
-1.97%
GH - NEPH
28%
Poorly correlated
-2.35%
AZTA - NEPH
25%
Poorly correlated
+1.38%
NEO - NEPH
24%
Poorly correlated
-2.02%
TNDM - NEPH
24%
Poorly correlated
+2.91%
More